BridgeBio Pharma's market cap is currently ―. The company's EPS TTM is $-3.949; its P/E ratio is -6.33; BridgeBio Pharma is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 1.75M	$ 4.09M	$ 1.64M	$ 1.83M	$ 1.87M
Gross Profit	$ -155.00K	$ 3.49M	$ 1.64M	$ 1.18M	$ 1.22M
EBIT	$ -143.72M	$ -151.54M	$ -132.47M	$ -130.25M	$ -120.58M
EBITDA	$ -142.13M	-	$ -130.83M	$ -128.62M	$ -118.92M
Net Income Common Stockholders	$ -168.15M	$ -177.00M	$ -157.90M	$ -140.16M	$ -137.59M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 434.88M	$ 543.26M	$ 403.72M	$ 516.80M	$ 471.92M
Total Assets	$ 546.38M	$ 655.01M	$ 503.66M	$ 625.68M	$ 623.04M
Total Debt	$ 459.55M	$ 455.67M	$ 455.19M	$ 451.34M	$ 1.72B
Net Debt	$ 24.67M	$ -87.59M	$ 51.46M	$ -65.45M	$ 1.25B
Total Liabilities	$ 1.89B	$ 1.85B	$ 1.85B	$ 1.84B	$ 1.87B
Stockholders Equity	$ -1.35B	$ -1.21B	$ -1.36B	$ -1.23B	$ -1.25B
Cash Flow	-
Free Cash Flow	$ -125.25M	-	$ -113.78M	$ -144.33M	$ -94.04M
Operating Cash Flow	$ -124.82M	$ -145.23M	$ -113.35M	$ -144.32M	$ -93.24M
Investing Cash Flow	$ -66.00K	$ 37.68M	$ 4.12M	$ 12.30M	$ 17.96M
Financing Cash Flow	$ -4.52M	$ 307.04M	$ -1.23M	$ 150.25M	$ 6.38M

Currency in USD

BridgeBio Pharma Earnings and Revenue History

Income Statement >

BridgeBio Pharma Debt to Assets

Balance Sheet >

BridgeBio Pharma Cash Flow

Cash Flow >

BridgeBio Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing